Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
Intervalo de año de publicación
1.
Toxicology ; 425: 152250, 2019 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-31326399

RESUMEN

Evidence suggests that low concentration perinatal exposure to environmental contaminants, such as organophosphate (OP) is associated with later life insulin resistance and type 2 diabetes. The aim of this work was to investigate whether chronic maternal OP exposure exacerbates metabolic dysfunctions in early-overfed rats. During pregnancy and lactational periods, dams received OP by gavage. To induce neonatal overnutrition at postnatal day 3, pups were standardized to 9 or 3 per nest. At 90-days-old, glucose-insulin homeostasis and insulin release from pancreatic islets were analyzed. While both OP exposure and overfeeding alone did induce diabetogenic phenotypes in adulthood, there was no exacerbation in rats that experienced both. Unexpectedly, the group that experienced both had improved adiposity, metabolic parameters, attenuated insulin release from isolated islets in the presence of glucose and low function of muscarinic acetylcholine receptor M3, as well as an attenuation of beta cell mass hyperplasia. High levels of butyrylcholinesterase and low levels of insulin in milk may contribute to the OP-induced developmental programming. Our study showed that maternal OP exposure may program insulin release as well as endocrine pancreas structure, thus affecting metabolism in adulthood. Our data suggest that while perinatal OP exposure alone increases the risk for later life T2D, it actually reverses many of the programmed metabolic dysfunction that is induced by postnatal overfeeding. These surprising results may suggest that low-dose administration of acetylcholinesterase inhibitors could be of utility in preventing detrimental developmental programming that is caused by early-life overnutrition.


Asunto(s)
Inhibidores de la Colinesterasa/farmacología , Exposición Materna , Enfermedades Metabólicas/tratamiento farmacológico , Organofosfatos/farmacología , Hipernutrición/tratamiento farmacológico , Animales , Animales Recién Nacidos , Glucemia/análisis , Composición Corporal/efectos de los fármacos , Inhibidores de la Colinesterasa/administración & dosificación , Ingestión de Energía/efectos de los fármacos , Femenino , Prueba de Tolerancia a la Glucosa , Insulina/sangre , Islotes Pancreáticos/efectos de los fármacos , Islotes Pancreáticos/metabolismo , Masculino , Enfermedades Metabólicas/etiología , Organofosfatos/administración & dosificación , Hipernutrición/complicaciones , Embarazo , Efectos Tardíos de la Exposición Prenatal/tratamiento farmacológico , Ratas , Ratas Wistar
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA